Immunogen, Inc. (IMGN) Misses Q3 Expectations
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.44), $0.17 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $13.28 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Stardust Power (SDST) Tops Q2 EPS by 1c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
